[PDF][PDF] The epidemiology of heart failure

MR Cowie, A Mosterd, DA Wood… - European heart …, 1997 - researchgate.net
Methods The Medline Literature Database from January 1966 to June 1995 was searched
using the medical subject headings heart failure (congestive), cardiomyopathy (congestive) …

Cardiovascular reactivity and development of preclinical and clinical disease states

FA Treiber, T Kamarck, N Schneiderman… - Psychosomatic …, 2003 - journals.lww.com
Objective The objective of this review is to evaluate the evidence for the hypothesis that
cardiovascular reactivity can predict the development of preclinical (elevated blood …

Epidemiology of smoking-induced cardiovascular disease

DM Burns - Progress in cardiovascular diseases, 2003 - Elsevier
Cigarette smoking is a major cause of coronary heart disease, stroke, aortic aneurysm, and
peripheral vascular disease. The risk is manifest both as an increased risk for thrombosis of …

Influence of race, sex, and age on management of unstable angina and non—Q-wave myocardial infarction: The TIMI III Registry

PH Stone, B Thompson, HV Anderson… - Jama, 1996 - jamanetwork.com
Objective.—To investigate the natural history and response to treatment of patients with
unstable angina or non—Q-wave myocardial infarction (MI). Design.—Inception cohort …

Racial differences in the use of cardiac catheterization after acute myocardial infarction

J Chen, SS Rathore, MJ Radford, Y Wang… - … England Journal of …, 2001 - Mass Medical Soc
Background Several studies have reported that black patients are less likely than white
patients to undergo cardiac catheterization after acute myocardial infarction. The role of the …

Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial

HD White, GI Barbash, RM Califf, RJ Simes… - Circulation, 1996 - Am Heart Assoc
Background Elderly patients with acute myocardial infarction have much to gain from
reperfusion with thrombolytic therapy but are also at increased risk of adverse events. We …

Surrogate endpoints in clinical trials: cardiovascular diseases

J Wittes, E Lakatos, J Probstfield - Statistics in medicine, 1989 - Wiley Online Library
A surrogate endpoint in a cardiovascular clinical trial is defined as endpoint measured in
lieu of some other so‐called 'true'endpoint. A surrogate is especially useful if it is easily …

Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs

ED Peterson, SM Wright, J Daley, GE Thibault - Jama, 1994 - jamanetwork.com
Objective.—To examine whether blacks admitted to Veterans Affairs Medical Centers
(VAMCs) with an acute myocardial infarction (AMI) are less likely than whites to undergo …

Thrombolysis for acute myocardial infarction

HD White, FJJ Van de Werf - Circulation, 1998 - Am Heart Assoc
Thrombolytic therapy has been a major advance in the management of acute myocardial
infarction. Unfortunately, it continues to be underused or is administered later than is …

Racial differences in the elderly's use of medical procedures and diagnostic tests.

JJ Escarce, KR Epstein, DC Colby… - American journal of …, 1993 - ajph.aphapublications.org
OBJECTIVES. This study sought to examine racial differences in the use of medical
procedures and diagnostic tests by elderly Americans. METHODS. We used 1986 physician …